{
  "denotations": [
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 89,
        "end": 95
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 241,
        "end": 249
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "22571356_5",
  "text": "Homozygosity for the -1639 G>A single nucleotide functional promoter polymorphism of the VKORC1 gene ( genotype AA ; 14 5 % of cases ) was associated with a significantly shortened time to therapeutic INR > = 2 ( P < 0 01 ) , reduced stable warfarin dose ( P < 0 01 ) , and an increased number of INRs > 5 ( P < 0 001 ) and occurrence of bleeding events ( P < 0 01 ) during the first month , as compared to the GG genotype ."
}
